AddLife AB
STO:ALIF B

Watchlist Manager
AddLife AB Logo
AddLife AB
STO:ALIF B
Watchlist
Price: 132 SEK 0.23% Market Closed
Market Cap: 16.1B SEK
Have any thoughts about
AddLife AB?
Write Note

AddLife AB
Cash from Investing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

AddLife AB
Cash from Investing Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Investing Activities CAGR 3Y CAGR 5Y CAGR 10Y
AddLife AB
STO:ALIF B
Cash from Investing Activities
-kr317m
CAGR 3-Years
10%
CAGR 5-Years
4%
CAGR 10-Years
N/A
BICO Group AB
STO:BICO
Cash from Investing Activities
-kr129.7m
CAGR 3-Years
46%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Biotage AB
STO:BIOT
Cash from Investing Activities
-kr379m
CAGR 3-Years
-80%
CAGR 5-Years
-35%
CAGR 10-Years
-28%
G
Genovis AB
STO:GENO
Cash from Investing Activities
-kr9.9m
CAGR 3-Years
-18%
CAGR 5-Years
-24%
CAGR 10-Years
4%
MedCap AB (publ)
STO:MCAP
Cash from Investing Activities
-kr119.1m
CAGR 3-Years
-17%
CAGR 5-Years
-35%
CAGR 10-Years
-57%
M
Magle Chemoswed Holding AB
STO:MAGLE
Cash from Investing Activities
-kr20.4m
CAGR 3-Years
-14%
CAGR 5-Years
1%
CAGR 10-Years
N/A
No Stocks Found

AddLife AB
Glance View

Market Cap
16.1B SEK
Industry
Life Sciences Tools & Services

AddLife AB engages in the ownership and acquisition of companies in niche segments under the healthcare sector. The company is headquartered in Stockholm, Stockholm. The company went IPO on 2015-03-16. The firm markets and sells instruments, equipment, consumables and related services mainly to the healthcare sector. The firm operates through two segments: The LabTech segment is engaged in the sales of laboratory equipment, analytical instruments and reagents, that are used for diagnostics or biomedical research; The MedTech segment offers various medical device equipment, consumables, instruments and devices, primarily to hospitals. The firm operates through number of subsidiaries, such as BergmanLabora AB, BioNordica group, Holm & Halby A/S, Immuno Diagnostic Oy, LabRobot Products AB, Triolab-group, Active Care Sverup AB, Fenno Medical Oy, Mediplast AB, among others.

ALIF B Intrinsic Value
161.48 SEK
Undervaluation 18%
Intrinsic Value
Price

See Also

What is AddLife AB's Cash from Investing Activities?
Cash from Investing Activities
-317m SEK

Based on the financial report for Dec 31, 2023, AddLife AB's Cash from Investing Activities amounts to -317m SEK.

What is AddLife AB's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 5Y
4%

Over the last year, the Cash from Investing Activities growth was 71%. The average annual Cash from Investing Activities growth rates for AddLife AB have been 10% over the past three years , 4% over the past five years .

Back to Top